APA (7th ed.) Citation

DH, K., SY, K., HJ, H., NY, L., WJ, K., & BW, J. (2023). In Vitro Activity of Rifamycin Derivatives against Nontuberculous Mycobacteria, including Macrolide-/Amikacin-Resistant Clinical Isolates. Antimicrobial agents and chemotherapy, 65(5), . https://doi.org/10.1128/AAC.02611-20

Chicago Style (17th ed.) Citation

DH, Kim, Kim SY, Huh HJ, Lee NY, Koh WJ, and Jhun BW. "In Vitro Activity of Rifamycin Derivatives Against Nontuberculous Mycobacteria, Including Macrolide-/Amikacin-Resistant Clinical Isolates." Antimicrobial Agents and Chemotherapy 65, no. 5 (2023). https://doi.org/10.1128/AAC.02611-20.

MLA (9th ed.) Citation

DH, Kim, et al. "In Vitro Activity of Rifamycin Derivatives Against Nontuberculous Mycobacteria, Including Macrolide-/Amikacin-Resistant Clinical Isolates." Antimicrobial Agents and Chemotherapy, vol. 65, no. 5, 2023, https://doi.org/10.1128/AAC.02611-20.